Boyds, MD, United States of America

Suja Hiriyanna


 

 

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2019-2023

Loading Chart...
Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Suja Hiriyanna: Innovator in Gene Therapy

Introduction

Suja Hiriyanna is a prominent inventor based in Boyds, Maryland, known for her significant contributions to the field of gene therapy. With a total of four patents to her name, she has made remarkable strides in developing innovative treatments for eye diseases.

Latest Patents

Among her latest patents are the RP2 and RPGR vectors for treating X-linked retinitis pigmentosa. These patents disclose adeno-associated virus (AAV) vectors that comprise a nucleotide sequence encoding RP2 or RPGR-ORF15, along with related pharmaceutical compositions. The patents also detail methods for treating or preventing X-linked retinitis pigmentosa, increasing photoreceptor numbers in the retina of mammals, and enhancing visual acuity. Additionally, she has developed methods and compositions for treating Leber congenital amaurosis, which include expression vectors, viral particles, and therapeutic methods aimed at improving visual function in patients suffering from eye diseases caused by the failure to produce specific proteins.

Career Highlights

Suja has worked with esteemed organizations, including the National Institutes of Health, a component of the U.S. Department of Health & Human Services. Her work has been pivotal in advancing the understanding and treatment of genetic eye disorders.

Collaborations

Throughout her career, Suja has collaborated with notable colleagues, including Zhijian Wu and Anand Swaroop, contributing to a rich exchange of ideas and innovations in her field.

Conclusion

Suja Hiriyanna's work in gene therapy exemplifies the impact of innovative research on treating genetic eye diseases. Her patents and collaborations highlight her commitment to improving visual health and advancing medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…